CNTB Latest Headlines

Buy Rating Maintained on CNTB as Rademikibart Data Supports Upside; $7 Price Target Reiterated

at www.tipranks.com (Thu, 17-Sep 6:25 AM)

CNTB climbs after Phase 2 asthma data shows 130 mL FEV1 edge at Day 7 and a 66% drop in treatment failures

Market Chameleon (Wed, 16-Sep 11:05 AM)

Connect Biopharma Holdings (CNTB) Receives a Buy from Leerink Partners

at www.tipranks.com (Wed, 16-Sep 8:55 AM)

Analysts Are Bullish on These Healthcare Stocks: Nuvation Bio (NUVB), Connect Biopharma Holdings (CNTB)

at www.tipranks.com (Tue, 15-Sep 9:20 AM)

Connect Biopharma drops as asthma candidate fails in mid-stage trial

at seekingalpha.com (Tue, 15-Sep 8:04 AM)

Connect Biopharma reports positive Phase 2 asthma results

at www.tipranks.com (Tue, 15-Sep 7:27 AM)